M&A Deal Summary

Mylan Laboratories Acquires Penederm

On June 24, 1998, Mylan Laboratories acquired life science company Penederm for 205M USD

Acquisition Highlights
  • This is Mylan Laboratories’ 1st transaction in the Life Science sector.
  • This is Mylan Laboratories’ largest (disclosed) transaction.
  • This is Mylan Laboratories’ 1st transaction in the United States.
  • This is Mylan Laboratories’ 1st transaction in California.

M&A Deal Summary
Date 1998-06-24
Target Penederm
Sector Life Science
Buyer(s) Mylan Laboratories
Deal Type Add-on Acquisition
Deal Value 205M USD

Target

Penederm

Foster City, California, United States
Penederm, Inc. develops and markets patented topically administered prescription products. The company currently markets three prescription products to dermatologists in the U.S. through a 41 person direct sales force.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mylan Laboratories

Secunderabad, India
Category Company
Sector Medical Products
Employees3,000
DESCRIPTION

Mylan Laboratories Limited (Mylan Labs), a subsidiary of U.S.-based Mylan Inc. (Nasdaq: MYL), is one of the world’s largest manufacturers and suppliers of active pharmaceutical ingredients (APIs). Based in Hyderabad, India, Mylan Labs offers more than 150 APIs and intermediates to customers in more than 80 countries across a wide range of therapeutic categories.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (1998) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal